ES2571127T3 - Método para la separación de moléculas o partículas objetivo a partir de muestras que contienen fibrinógeno, incluyendo componentes sanguíneos - Google Patents
Método para la separación de moléculas o partículas objetivo a partir de muestras que contienen fibrinógeno, incluyendo componentes sanguíneosInfo
- Publication number
- ES2571127T3 ES2571127T3 ES11788227T ES11788227T ES2571127T3 ES 2571127 T3 ES2571127 T3 ES 2571127T3 ES 11788227 T ES11788227 T ES 11788227T ES 11788227 T ES11788227 T ES 11788227T ES 2571127 T3 ES2571127 T3 ES 2571127T3
- Authority
- ES
- Spain
- Prior art keywords
- particles
- target molecules
- separation
- samples containing
- fibrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010049003 Fibrinogen Proteins 0.000 title abstract 3
- 102000008946 Fibrinogen Human genes 0.000 title abstract 3
- 229940012952 fibrinogen Drugs 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000000926 separation method Methods 0.000 title abstract 2
- 239000012503 blood component Substances 0.000 title 1
- 102000009123 Fibrin Human genes 0.000 abstract 6
- 108010073385 Fibrin Proteins 0.000 abstract 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 6
- 229950003499 fibrin Drugs 0.000 abstract 6
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
- 230000002345 thrombinlike Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/14—Streptococcus; Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Método para el procesamiento de una muestra líquida que comprende fibrinógeno, para la separación y concentración de moléculas o partículas objetivo de la muestra, que comprende: a. Atrapar dichas moléculas o partículas objetivo en una red de fibrina sometiendo la muestra a trombina o enzimas de tipo trombina para convertir, como mínimo, parcialmente el fibrinógeno contenido en la dicha muestra en fibrina para formar la red de fibrina b. Retraer dicha red de fibrina para formar un coágulo de fibrina c. Separar de dicho coágulo de fibrina del medio de muestra circundante.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH14782010 | 2010-09-15 | ||
| CH20412010 | 2010-12-07 | ||
| CH12072011 | 2011-07-20 | ||
| PCT/IB2011/054035 WO2012035508A2 (en) | 2010-09-15 | 2011-09-15 | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2571127T3 true ES2571127T3 (es) | 2016-05-24 |
Family
ID=45044632
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11788227T Active ES2571127T3 (es) | 2010-09-15 | 2011-09-15 | Método para la separación de moléculas o partículas objetivo a partir de muestras que contienen fibrinógeno, incluyendo componentes sanguíneos |
| ES16154770T Active ES2751660T3 (es) | 2010-09-15 | 2011-09-15 | Dispositivo que incluye componentes sanguíneos para separar moléculas o partículas diana de muestras |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16154770T Active ES2751660T3 (es) | 2010-09-15 | 2011-09-15 | Dispositivo que incluye componentes sanguíneos para separar moléculas o partículas diana de muestras |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US9689881B2 (es) |
| EP (2) | EP2616550B1 (es) |
| JP (1) | JP5999776B2 (es) |
| KR (1) | KR101948944B1 (es) |
| CN (2) | CN107389932B (es) |
| AU (2) | AU2011303467C1 (es) |
| CA (1) | CA2811493C (es) |
| CY (1) | CY1122166T1 (es) |
| DK (2) | DK2616550T3 (es) |
| ES (2) | ES2571127T3 (es) |
| HR (1) | HRP20191785T1 (es) |
| HU (2) | HUE028915T2 (es) |
| LT (1) | LT3067431T (es) |
| PL (2) | PL3067431T3 (es) |
| PT (1) | PT3067431T (es) |
| SI (1) | SI3067431T1 (es) |
| WO (1) | WO2012035508A2 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3067431T (lt) | 2010-09-15 | 2019-11-11 | Debiopharm Int Sa | Įrenginys, turintis kraujo komponentus, skirtas atskirti tikslines molekules ar daleles iš mėginių |
| CN108671224B (zh) | 2011-06-27 | 2022-12-13 | 爱默蕾大学 | 血小板裂解物的组合物、用途和制备 |
| EP2979093B1 (en) * | 2013-03-29 | 2019-10-23 | Siemens Healthcare Diagnostics Inc. | Rare cell concentration |
| SI3148698T1 (sl) * | 2014-06-01 | 2019-09-30 | Debiopharm International Sa Forum "Apres-Demain" | Naprava za jemanje in obdelavo vzorcev |
| US12397302B2 (en) | 2015-11-30 | 2025-08-26 | Dh Technologies Development Pte. Ltd. | Electromagnetic assemblies for processing fluids |
| US10596236B2 (en) | 2016-03-10 | 2020-03-24 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
| EP3426400B1 (en) | 2016-03-10 | 2020-09-02 | Arthrex Inc | System for preparing protein enhanced serums |
| IL280880B2 (en) | 2018-08-27 | 2025-04-01 | Regeneron Pharma | Using Raman Spectroscopy in Downstream Purification |
| JP7298449B2 (ja) * | 2019-11-14 | 2023-06-27 | 株式会社島津製作所 | 血液凝固分析装置、及び分注ノズルの洗浄方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1035260A (en) * | 1974-08-12 | 1978-07-25 | Baxter Travenol Laboratories | Collection and processing tube |
| FR2625321B1 (fr) * | 1987-12-24 | 1992-10-02 | Pasteur Institut | Reactif pour le diagnostic de staphylococcus aureus par agglutination |
| DE3803463A1 (de) * | 1988-02-05 | 1989-08-17 | Linhart Axel | Semiquantitativer kalzium-schnelltest |
| EP0325106B1 (de) * | 1988-01-05 | 1992-10-21 | Axel Dr. Linhart | Verfahren und Test-Kit zur semiquantitativen Bestimmung des Kalziumgehaltes im Blut |
| US5691160A (en) * | 1992-08-14 | 1997-11-25 | Biogen, Inc. | Effects of actin filaments of fibrin clot structure and lysis |
| DE69316293T2 (de) * | 1992-09-09 | 1998-08-27 | Tokuyama Corp | Methode zur Bestimmung von Fibrinogen, trockenes Reagens hierfür und Verfahren zur Herstellung desselben |
| JP3292760B2 (ja) * | 1993-04-22 | 2002-06-17 | テルモ株式会社 | 採血管およびその製造方法 |
| US5670329A (en) * | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
| CA2176810A1 (en) | 1993-12-03 | 1995-06-08 | Gordon L. Dorn | Method for improving quantitative recovery of microorganisms from speci mens containing blood components |
| DE19602673A1 (de) * | 1996-01-25 | 1997-08-07 | Pereg Gmbh | Synthetische Testanschmutzung |
| US6121232A (en) * | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| US6680195B1 (en) * | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| JP2000262499A (ja) * | 2000-01-01 | 2000-09-26 | Terumo Corp | 採血管 |
| US6686204B2 (en) * | 2001-08-27 | 2004-02-03 | Becton, Dickinson & Company | Collection device |
| JP2005508925A (ja) * | 2001-10-03 | 2005-04-07 | クリストファー ジェイ ウールヴァートン | 貯蔵安定なフィブリノーゲン溶液 |
| EP1504269B1 (en) * | 2002-05-01 | 2007-07-25 | Synapse B.V. | Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media |
| WO2005021799A2 (en) * | 2003-08-15 | 2005-03-10 | University Of South Florida | Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample |
| ATE335816T1 (de) | 2002-09-18 | 2006-09-15 | Sirs Lab Gmbh | Verfahren zum nachweis prokaryontischer dna |
| US20050065454A1 (en) * | 2003-09-22 | 2005-03-24 | Becton, Dickinson And Company | Non-evacuated blood collection tube |
| US7399609B2 (en) * | 2003-12-30 | 2008-07-15 | 3M Innovative Properties Company | Staphylococcus detection |
| US8419722B2 (en) * | 2004-10-29 | 2013-04-16 | Spinal Restoration, Inc. | Apparatus and method for injection of fibrin sealant in spinal applications |
| DE102005009479A1 (de) | 2005-03-02 | 2006-09-07 | Molzym Gmbh & Co. Kg | Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden |
| US20100009409A1 (en) * | 2005-07-29 | 2010-01-14 | Ecole Polytechnique Federale De Lausanne | Molecular variant fibrinogen fusion proteins |
| ES2387700T3 (es) * | 2007-05-03 | 2012-09-28 | Accumetrics, Inc. | Métodos para medir la inhibición de la agregación de plaquetas mediante antagonistas del receptor de trombina |
| EP2185681B1 (en) | 2007-08-02 | 2014-12-17 | Université Laval | Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids |
| JP5029217B2 (ja) * | 2007-08-27 | 2012-09-19 | 東レ株式会社 | シート状物の製造方法 |
| PL2310411T3 (pl) * | 2008-07-09 | 2017-02-28 | Profibrix Bv | Rekombinowany fibrynogen |
| AU2010272505B2 (en) | 2009-07-16 | 2015-09-17 | Glaxosmithkline Biologicals S.A. | Treatment of infections |
| LT3067431T (lt) | 2010-09-15 | 2019-11-11 | Debiopharm Int Sa | Įrenginys, turintis kraujo komponentus, skirtas atskirti tikslines molekules ar daleles iš mėginių |
-
2011
- 2011-09-15 LT LT16154770T patent/LT3067431T/lt unknown
- 2011-09-15 EP EP11788227.4A patent/EP2616550B1/en active Active
- 2011-09-15 PL PL16154770T patent/PL3067431T3/pl unknown
- 2011-09-15 JP JP2013528815A patent/JP5999776B2/ja active Active
- 2011-09-15 DK DK11788227.4T patent/DK2616550T3/en active
- 2011-09-15 WO PCT/IB2011/054035 patent/WO2012035508A2/en not_active Ceased
- 2011-09-15 ES ES11788227T patent/ES2571127T3/es active Active
- 2011-09-15 CN CN201710338814.XA patent/CN107389932B/zh active Active
- 2011-09-15 HU HUE11788227A patent/HUE028915T2/en unknown
- 2011-09-15 AU AU2011303467A patent/AU2011303467C1/en active Active
- 2011-09-15 US US13/822,209 patent/US9689881B2/en active Active
- 2011-09-15 HU HUE16154770A patent/HUE045771T2/hu unknown
- 2011-09-15 EP EP16154770.8A patent/EP3067431B1/en active Active
- 2011-09-15 CN CN201180044211.XA patent/CN103108959B/zh active Active
- 2011-09-15 CA CA2811493A patent/CA2811493C/en active Active
- 2011-09-15 SI SI201131797T patent/SI3067431T1/sl unknown
- 2011-09-15 PT PT161547708T patent/PT3067431T/pt unknown
- 2011-09-15 DK DK16154770.8T patent/DK3067431T3/da active
- 2011-09-15 KR KR1020137009329A patent/KR101948944B1/ko active Active
- 2011-09-15 PL PL11788227T patent/PL2616550T3/pl unknown
- 2011-09-15 ES ES16154770T patent/ES2751660T3/es active Active
-
2016
- 2016-12-02 AU AU2016266066A patent/AU2016266066B2/en active Active
-
2017
- 2017-05-22 US US15/601,677 patent/US20170336424A1/en not_active Abandoned
-
2019
- 2019-10-02 HR HRP20191785TT patent/HRP20191785T1/hr unknown
- 2019-10-11 CY CY20191101074T patent/CY1122166T1/el unknown
-
2021
- 2021-01-28 US US17/160,814 patent/US20210148940A1/en not_active Abandoned
-
2023
- 2023-08-09 US US18/231,880 patent/US20240280593A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2571127T3 (es) | Método para la separación de moléculas o partículas objetivo a partir de muestras que contienen fibrinógeno, incluyendo componentes sanguíneos | |
| GB2519906A (en) | Methods and systems for detecting biological components | |
| BR112013025758A2 (pt) | monitoramento de misturas de amplificação de recombinase polimerase | |
| WO2013126774A3 (en) | Microfluidic devices for capture of target species | |
| CR20120326A (es) | Dispositivo portátil de monitorización de la coagulación y método de evaluación de la respuesta de coagulación | |
| EA201491833A1 (ru) | Основанные на клетках перекрестные анализы и их применение | |
| TR201906285T4 (tr) | İntraoperatif otolog kan kurtarımından tümör hücrelerinin giderilmesi. | |
| MX2021003761A (es) | Centrifuga compacta de alta velocidad para utilizarse con peque?os volumenes de muestra. | |
| BR112014010718A2 (pt) | métodos e sistemas para detecção de analito em amostra | |
| WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
| WO2012122564A3 (en) | Diagnostic and sample preparation devices and methods | |
| MX351846B (es) | Preparacion de suero. | |
| MX358997B (es) | Metodo para evaluar la reaccion de coagulacion sanguinea. | |
| EA201291396A1 (ru) | Способ детекции молекулярных взаимодействий | |
| EA201490823A1 (ru) | Агенты, реверсирующие действие антикоагулянтов | |
| WO2012040603A3 (en) | Use of diazolidinyl urea for anti-clumping of biological samples | |
| CY1123698T1 (el) | Εμπλουτισμος κυκλοφορουντων κυτταρων ογκου μεσω εξαντλησης λευκων αιμοσφαιριων | |
| PE20190517A1 (es) | Preparacion farmaceutica antienvejecimiento | |
| WO2010011358A3 (en) | Method and medium for detecting the presence or absence of staphylococcus aureus in a test sample | |
| IN2015DN01608A (es) | ||
| BR112014015424A2 (pt) | detecção de células derivadas de tecido do cordão umbilical humano | |
| WO2014184684A3 (en) | Methods and biomarkers for detection of hematological cancers | |
| CL2014002976A1 (es) | Metodo de analisis de una muestra biologica de un sujeto con cancer utilizando biomarcadores tnf, ripk1, cxl10, ccl5, nfkbia, herc5, cdyl, stk39 y mapk14 para la terapia inhibitoria con iap. | |
| PL403996A1 (pl) | Sposób jednoczesnej detekcji bakterii i grzybów w preparacie biologicznym metodą PCR, startery oraz zestaw do detekcji bakterii i grzybów | |
| WO2012015219A3 (en) | Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry |